RxDoctor Payments Data

Monica Averia-Suboc, NP

Nurse Practitioner · Los Angeles, CANPI 1508008129

Payments from drug & device makers

$1,724in general payments, 2019–2025

Across 64 payments — averaging $26.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$535
  • Sobi, Inc$221
  • Merck$187
  • Incyte Corporation$120
  • Syndax Pharmaceuticals, Inc.$103
  • Bayer$99
  • plus $460 from 11 others

What the payments were for

  • Food & beverage$1,53789%
  • Education$18711%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,724 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$24,967
Medicare patients
98
Services billed
222

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide61$773,361
CabometyxCabozantinib S-Malate35$753,505
NubeqaDarolutamide47$636,713
InlytaAxitinib21$362,325
Pazopanib Hcl13$109,275
OrgovyxRelugolix17$45,008
Abiraterone Acetate83$35,733
LysodrenMitotane14$32,780
SynthroidLevothyroxine Sodium12$632
Ondansetron Hcl21$365
Prednisone87$338
Levothyroxine Sodium29$254

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Exelixis Inc.Cabometyx$23$753,50535 claims
BayerNubeqa$99$636,71347 claims
PfizerInlyta$42$362,32521 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →